Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosis

Abstract Background Toxoplasma gondii is an obligate intracellular parasite that can infect almost all warm-blooded animals, avian species and humans. Toxoplasmosis is asymptomatic in healthy individuals, whereas it may lead to death in immune suppressed or deficient patients. A vaccine against T. g...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Esra Atalay Şahar, Hüseyin Can, Sultan Gülçe İz, Aysu Değirmenci Döşkaya, Mina Kalantari-Dehaghi, Remziye Deveci, Adnan Yüksel Gürüz, Mert Döşkaya
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2020-07-01
Serija:	BMC Infectious Diseases
Teme:	Toxoplasma gondii Recombinant protein vaccine Hexavalant Adjuvant Montanide ISA 50 V
Online dostop:	http://link.springer.com/article/10.1186/s12879-020-05220-2
Oznake:	Označite Brez oznak, prvi označite!